In a study of 187 Austrian participants, Feldman et al. [28] observed a higher rate of PNPLA3 risk alleles in lean individuals with NAFLD compared with the lean control group, with a frequency comparable to NAFLD patients with obesity. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.